Evidence map›Paper›PMID 41868593›Full record

ArticleJournal of acute medicine2026

Clinical Characteristics and Factors Associated With Critical Illness and Mortality in Patients Hospitalized With COVID-19: A Retrospective Cohort Study in Taiwan.

Jia-Lun Huang, Hong-Mo Shih, Yi-Da Sie

Abstract read
In one paragraph

Article in Journal of acute medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jia-Lun HuangDepartment of Emergency Medicine China Medical University Hospital Taichung Taiwan.
Hong-Mo ShihDepartment of Emergency Medicine China Medical University Hospital Taichung Taiwan.
Yi-Da SieDepartment of Emergency Medicine China Medical University Hospital Taichung Taiwan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The ongoing COVID-19 pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has led to significant morbidity and mortality worldwide. Identifying the clinical features and factors influencing severe disease and mortality in individuals hospitalized with COVID-19 is essential for informing clinical management strategies and optimizing healthcare resource distribution. Methods: We conducted a retrospective cohort study of 684 patients hospitalized with COVID-19 at a single center in Taiwan between April and June 2022. Demographic characteristics, comorbidities, vaccination status, and clinical outcomes were compared among different age groups (< 50 years, 50-74 years, and ≥ 75 years). Logistic regression analyses were performed to identify factors associated with critical illness and mortality. Results: The median age of the cohort was 72 years (interquartile range [IQR]: 58-82), and 59.6% were male. Older patients had a significantly higher prevalence of comorbidities. The overall rates of mortality and critical illness were 15.1% and 30.4%, respectively. There were no significant differences in the occurrence of critical illness among the age groups. However, mortality was significantly higher in patients aged ≥ 50 years. In the multivariate analysis, oral antiviral drug use (adjusted odds ratio [aOR]: 0.5, 95% CI [confidence interval]: 0.3-0.7) and being fully vaccinated (aOR: 0.6, 95% CI: 0.4-0.8) were associated with lower mortality, while having ≥ 3 risk factors (aOR: 1.9, 95% CI: 1.2-3.0) was associated with higher mortality. Additionally, age ≥ 50 years was associated with increased mortality; 50-74 years (aOR: 2.3, 95% CI: 1.1-4.8); ≥ 75 years (aOR: 2.3, 95% CI: 1.1-4.8) compared to age < 50 years. Similar factors were associated with critical illness. Conclusions: Older age was associated with higher mortality but not with an increased risk of critical illness in patients hospitalized with COVID-19. Oral antiviral drug use and being fully vaccinated were associated with better outcomes, highlighting the importance of early treatment and vaccination in mitigating severe COVID-19.

Indexed as

ageCOVID-19critical illnessmortalityTaiwan

Identifiers

PMID41868593
PMCPMC13004699

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.